Cardiac arrest - Nursing Case Study
Pathophysiology
• Primary mechanism: Electrical Dysfunction - Cardiac arrest often results from arrhythmias like ventricular fibrillation or pulseless ventricular tachycardia. These disrupt the heart’s electrical signals, causing ineffective heart contractions and cessation of blood flow.
• Secondary mechanism: Myocardial Ischemia - Reduced or blocked blood flow to the heart muscle can lead to ischemia, impairing the heart’s ability to function properly and potentially triggering electrical instability and cardiac arrest.
• Key complication: Systemic Hypoperfusion - The immediate cessation of cardiac output leads to a lack of oxygenated blood to vital organs, rapidly resulting in tissue damage, irreversible brain injury, or death if not promptly reversed.
Patient Profile
Demographics:
52-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes
• Current medications: Lisinopril, Metformin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sudden collapse at worksite
• Key symptoms: Unconsciousness, shortness of breath, chest pain prior to collapse
• Vital signs: Blood pressure 88/56 mmHg, heart rate 120 bpm, respiratory rate 24 breaths per minute, oxygen saturation 85% on room air, temperature 98.6°F
Section 1
Following the patient's initial collapse, a rapid response team is immediately activated. Upon arrival, the team initiates Advanced Cardiovascular Life Support (ACLS) protocols, including chest compressions and defibrillation, as the patient is found to be in ventricular fibrillation. After two cycles of CPR and two defibrillation attempts, return of spontaneous circulation (ROSC) is achieved. However, the patient remains unconscious and is intubated for airway protection and ventilation support. His vital signs post-ROSC indicate a blood pressure of 95/60 mmHg, heart rate of 110 bpm, respiratory rate of 18 breaths per minute (via mechanical ventilation), and oxygen saturation improving to 92% on 100% oxygen.
Following stabilization, further diagnostic evaluations are conducted to assess the extent of myocardial damage and secondary complications. A 12-lead ECG reveals ST-segment elevation in the anterior leads, indicative of an acute myocardial infarction, likely precipitating the cardiac arrest. Laboratory tests show elevated cardiac biomarkers, with troponin levels significantly increased, confirming myocardial injury. Additionally, the patient's blood glucose is measured at 280 mg/dL, suggesting poor glycemic control, which may have contributed to endothelial dysfunction and heightened cardiovascular risk.
As the patient is transferred to the intensive care unit for further management, the focus shifts to addressing myocardial ischemia and preventing further complications. The patient is started on a heparin drip to prevent thrombus propagation, and plans are made for urgent coronary angiography to identify and potentially revascularize any occluded coronary arteries. Despite initial stabilization, there is concern for potential complications such as cardiogenic shock, given the patient's persistent hypotension and tachycardia, necessitating close hemodynamic monitoring and potential inotropic support. The medical team remains vigilant for signs of systemic hypoperfusion, which could compromise organ function if not promptly addressed.
Section 2
As the patient settles into the intensive care unit, the medical team closely monitors his hemodynamic status. Despite the initiation of a heparin drip and plans for coronary angiography, the patient's blood pressure remains concerningly low, with readings averaging around 88/55 mmHg. The heart rate, though still elevated, shows a slight decrease to 105 bpm, potentially indicative of compensatory mechanisms at play. Continuous ECG monitoring reveals persistent ST-segment elevation, suggesting ongoing myocardial ischemia despite initial interventions. The patient's oxygen saturation remains stable at 94% on 100% oxygen via mechanical ventilation, but there is a growing concern regarding the adequacy of tissue perfusion.
New laboratory results reveal further complications. The patient's arterial blood gas analysis shows a metabolic acidosis with a pH of 7.32, bicarbonate level of 18 mEq/L, and an elevated lactate level of 4.5 mmol/L, indicating inadequate perfusion and possible impending cardiogenic shock. Renal function tests reveal a rising creatinine level, now at 2.1 mg/dL, up from a baseline of 1.0 mg/dL, suggesting acute kidney injury secondary to reduced renal perfusion. These findings prompt the medical team to consider the initiation of inotropic support to enhance cardiac output and improve systemic perfusion.
Amidst these developments, the patient begins to exhibit signs of decreased responsiveness, with pupils sluggishly reactive and a Glasgow Coma Scale score dropping to 6, necessitating continued sedation management and neuroprotection strategies. The medical team deliberates on the potential benefits of therapeutic hypothermia to mitigate neurological injury post-cardiac arrest. As they prepare for urgent coronary angiography, the focus remains on stabilizing the patient's hemodynamic status and ensuring that all organs receive adequate perfusion to prevent further deterioration. The unfolding scenario requires careful balancing of interventions to address the complex interplay of myocardial ischemia, potential cardiogenic shock, and multi-organ dysfunction.
Section 3
As the team prepares for coronary angiography, the patient's condition continues to evolve, presenting new challenges. A sudden drop in blood pressure to 78/48 mmHg alarms the team, prompting immediate bedside re-evaluation. Inotropic support with dobutamine is initiated to augment cardiac output and support systemic circulation. Despite these efforts, there is only a mild improvement in hemodynamic status, with blood pressure climbing to 82/50 mmHg, underscoring the severity of the patient's condition. The team recognizes the need for a comprehensive approach, integrating pharmacologic support with mechanical interventions if necessary.
Further diagnostic results reveal a concerning trend: the patient's troponin levels have risen significantly to 12 ng/mL, confirming ongoing myocardial damage. Additional ECG leads show more widespread ST-segment elevation, suggesting possible extension of ischemia. The risk of cardiogenic shock looms larger, and the team considers the potential benefits of an intra-aortic balloon pump (IABP) to alleviate cardiac workload and enhance coronary perfusion. Meanwhile, the patient's renal function continues to decline, with the creatinine level now at 2.5 mg/dL, indicating worsening acute kidney injury.
The patient's neurological status remains a critical concern. Despite sedation, there is minimal response to verbal stimuli, and the Glasgow Coma Scale score remains at 6, emphasizing the need for neuroprotection. The team decides to initiate therapeutic hypothermia, aiming to preserve neurological function in the wake of cardiac arrest. As preparations for coronary angiography proceed, the focus is on maintaining a delicate balance between aggressive intervention and supportive care, ensuring that each step taken maximizes the patient's chance of recovery while minimizing further complications. The unfolding scenario necessitates constant vigilance and adaptive clinical reasoning to navigate the complex interplay of ongoing myocardial ischemia, potential cardiogenic shock, and multi-organ dysfunction.
Section 4
As the team continues to manage the patient's precarious condition, new diagnostic results further complicate the clinical picture. A follow-up echocardiogram reveals significant left ventricular dysfunction, with an ejection fraction now estimated at 25%, indicating severe systolic impairment. This finding reinforces the suspicion of cardiogenic shock and highlights the critical need for optimizing cardiac support strategies. Additionally, repeat laboratory tests demonstrate a further elevation in brain natriuretic peptide (BNP) levels to 1500 pg/mL, confirming the extent of cardiac strain and volume overload. These data points further underscore the importance of implementing mechanical circulatory support without delay.
In light of these developments, the healthcare team expedites the placement of the intra-aortic balloon pump (IABP). The device is successfully inserted, and its immediate effects are monitored closely. Encouragingly, the patient's blood pressure begins to stabilize, rising to 95/60 mmHg, suggesting improved hemodynamic status and enhanced coronary perfusion. However, the team remains vigilant, aware that this intervention is not without risks, particularly in the context of the patient's declining renal function and altered mental status. Continuous renal replacement therapy (CRRT) is considered to address the worsening acute kidney injury, aiming to support renal function while managing fluid balance.
The patient's neurological condition remains unchanged, with the Glasgow Coma Scale score still at 6 despite the initiation of therapeutic hypothermia. Neurological monitoring is intensified, with frequent assessments to gauge any signs of improvement or deterioration. The team remains cautiously optimistic, recognizing the potential for gradual neurological recovery with sustained supportive care and timely intervention. As the patient is prepared for coronary angiography, the focus shifts to identifying and addressing the underlying coronary lesion responsible for the ongoing myocardial ischemia, while maintaining a comprehensive approach to managing the complex interplay of cardiac, renal, and neurological challenges. This integrative strategy aims to optimize outcomes and guide the next steps in the patient's journey toward recovery.
Section 5
As the clinical team continues to monitor the patient's status following the placement of the intra-aortic balloon pump (IABP), new diagnostic results emerge that further complicate the clinical picture. A coronary angiography reveals the presence of a critical stenosis in the left anterior descending artery, confirming the source of the patient's myocardial ischemia. The decision is made to proceed with percutaneous coronary intervention (PCI) to restore adequate blood flow. During the procedure, a drug-eluting stent is successfully placed, and subsequent angiographic views confirm improved coronary perfusion.
Despite the initial success of the intervention, the patient's condition remains guarded. Over the next few hours, the patient demonstrates signs of respiratory distress, with an increase in respiratory rate to 28 breaths per minute and oxygen saturation dipping to 88% on a non-rebreather mask. Auscultation reveals bilateral crackles, suggesting worsening pulmonary edema. This development prompts the team to initiate mechanical ventilation to ensure adequate oxygenation and reduce the work of breathing, while carefully managing fluid overload with diuretics and adjusting the parameters of the continuous renal replacement therapy (CRRT).
The patient's response to these interventions is closely monitored, with arterial blood gases showing a slight improvement in oxygenation but persistent metabolic acidosis, with a pH of 7.30 and bicarbonate level of 18 mEq/L. The team deliberates on the necessity of further hemodynamic support, considering the potential benefits of vasoactive medications to enhance cardiac output. Meanwhile, the patient's neurological status remains unchanged, maintaining a Glasgow Coma Scale score of 6. These intertwined challenges necessitate ongoing interdisciplinary collaboration to fine-tune the treatment plan, with a focus on stabilizing the cardiac, pulmonary, and renal systems while awaiting signs of neurological recovery.